Abstract: An infant support device for supporting an infant in a prone position, comprising a base with a front, a back, a top, a bottom and two side members, said base having a support surface extending between the side members on the top of the base; the support surface being defined by two portions: (I) a body support surface disposed proximate the front of the support device and terminating adjacent the front of the device, and (II) a leg support surface extending rearwardly from terminus of the body support surface toward the back of the device; and having a grip for retaining the posterior side of the legs of the infant and extending upwardly from the support surface between the side members; wherein an infant is supported in a prone position on the support surface between the side members, and the legs are supported on the leg support surface and are retained by said grip to minimize infant rollover toward a supine position.

Abstract: An infant support device for supporting an infant in a prone position, comprising a base with a front, a back, a top, a bottom and two side members, said base having a support surface extending between the side members on the top of the base; the support surface being defined by two portions: (I) a body support surface disposed proximate the front of the support device and terminating adjacent the front of the device, and (II) a leg support surface extending rearwardly from terminus of the body support surface toward the back of the device; and having a grip for retaining the posterior side of the legs of the infant and extending upwardly from the support surface between the side members; wherein an infant is supported in a prone position on the support surface between the side members, and the legs are supported on the leg support surface and are retained by said grip to minimize infant rollover toward a supine position.

Abstract: The present invention generally provides modified polypeptides which are capable of interacting with the Fas receptor, nucleic acids encoding such polypeptides, cell lines capable of expressing these nucleic acids and secreting the polypeptides, and antibodies that are specifically immunoreactive with these polypeptides. The compositions of the present invention are generally useful for elucidating and modeling aspects of Fas biochemistry in vitro and manipulating Fas biology in vivo.